CRIAX
Price
$12.84
Change
-$0.15 (-1.15%)
Updated
Sep 20 closing price
VIMSX
Price
$71.38
Change
-$0.13 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CRIAX vs VIMSX

Header iconCRIAX vs VIMSX Comparison
Open Charts CRIAX vs VIMSXBanner chart's image
CRM Small/Mid Cap Value Inst
Price$12.84
Change-$0.15 (-1.15%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Investor
Price$71.38
Change-$0.13 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CRIAX vs VIMSX Comparison Chart
Loading...
VS
CRIAX vs. VIMSX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIAX is a StrongBuy and VIMSX is a Buy.

FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 172B vs. CRIAX (173M). VIMSX pays higher dividends than CRIAX: VIMSX (1.38) vs CRIAX (0.72). CRIAX was incepted earlier than VIMSX: CRIAX (20 years) vs VIMSX (26 years). CRIAX is a more actively managed with annual turnover of: 42.00 vs. VIMSX (13.00). VIMSX has a lower initial minimum investment than CRIAX: VIMSX (3000) vs CRIAX (1000000). CRIAX annual gain was more profitable for investors over the last year : 26.55 vs. VIMSX (25.11). VIMSX return over 5 years is better than : 56.75 vs. CRIAX (12.64).
CRIAXVIMSXCRIAX / VIMSX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years26 years-
Gain YTD15.57212.557124%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets173M172B0%
Annual Yield % from dividends0.721.3852%
Returns for 1 year26.5525.11106%
Returns for 3 years-12.029.82-122%
Returns for 5 years12.6456.7522%
Returns for 10 years-25.06128.21-20%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INSE10.090.15
+1.51%
Inspired Entertainment
FOUR86.901.01
+1.18%
Shift4 Payments
CALT40.00-0.16
-0.40%
Calliditas Therapeutics AB
BCE35.04-0.15
-0.43%
BCE
ACST2.70-0.08
-2.88%
Acasti Pharma